The purpose of this study is to demonstrate the safety \& efficacy of the Adiana Transcervical Sterilization System for women who desire permanent birth control (female sterilization) by occlusion of the fallopian tubes.
Participants who demonstrated to be bilaterally occluded by hysterosalpingogram (HSG) evaluations are allowed to rely on the Adiana System for pregnancy prevention and enter the Wearing Period of follow-up. Secondary endpoints inlcude safety of device placement procedure and safety of device wearing. The adverse events recorded during the course of the study are entered under adverse events.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
770
Implantation of silicone matrix in fallopian tubes
Women's Health Research
Phoenix, Arizona, United States
Kaiser Permanente
Roseville, California, United States
1 Year Pregnancy Rate
Pregnancy rate is defined as the cumulative percentage of pregnancies occuring within the time frame. The primary endpoint for this study is the pregnancy prevention rate after one year of reliance on the Adiana System for pregnancy prevention. The pregnancy rate was evaluated for all participants who underwent successful bilateral treatment and who had demonstrated tubal occlusion by hysterosalpingogram (HSG) at the end of the Waiting Period.
Time frame: 1 year
Device Placement Rate
Defined as successful bilateral tubal access followed by successful bilateral RF treatment and matrix placement.
Time frame: After First Treatment Attempt
Device Placement Rate
Defined as successful bilateral tubal access followed by successful bilateral RF treatment and matrix placement.
Time frame: Including Second Treatment Attempt
Patient Satisfaction With Placement Procedure
Determined by verbal questions up to 48 hours post placement. Endpoint reported represents minimum percentage of participants reporting somewhat satisfied, satisfied or very satisfied.
Time frame: 48 hours
Patient Satisfaction With Device Wearing
Determined by verbal questions during periodic follow-up contacts. Endpoint reported represents minimum percentage of subjects reporting somewhat satisfied, satisfied or very satisfied.
Time frame: Waiting Period (1-Month, 2-Months, 3-Months)
Patient Satisfaction With Device Wearing
Determined by verbal questions during periodic follow-up contacts. Endpoint reported represents minimum percentage of subjects reporting somewhat satisfied, satisfied or very satisfied.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kaiser Permanente
San Rafael, California, United States
Reproductive Science Center
San Ramon, California, United States
Center for Fertility and Women's Health
New Britain, Connecticut, United States
Institute for Women's Health and Body
Wellington, Florida, United States
Center for Reproductive Medicine
Wichita, Kansas, United States
Newton-Wellesley Hospital
Newton, Massachusetts, United States
Minnesota Gynecology and Surgery
Edina, Minnesota, United States
St. Luke's Hospital
Chesterfield, Missouri, United States
...and 6 more locations
Time frame: Wearing Period (3-Months, 6-Months, 9-Months, 12-Months)
Patient Comfort With Placement Procedure
Determined by verbal questions two hours following procedure or at discharge from facility, whichever came first. Endpoint reported represents minimum percentage of participants reporting any discomfort or pain experienced during the procedure as the same as or less than they expected.
Time frame: Post-Procedure
Patient Comfort With Placement Procedure
Determined by verbal questions up to 48 hours post placement. Endpoint reported represents minimum percentage of participants reporting any discomfort or pain experienced in first 48 hours following procedure as the same as they expected, less than they expected or no pain.
Time frame: 48 hours
Patient Comfort With Device Wearing
Determined by verbal questions during periodic follow-up contacts. Endpoint represents minimum percentage of subjects reporting good, very good or excellent comfort.
Time frame: Waiting Period (1-Month, 2-Months, 3-Months)
Patient Comfort With Device Wearing
Determined by verbal questions during periodic follow-up contacts. Endpoint represents minimum percentage of subjects reporting good, very good or excellent comfort.
Time frame: Wearing Period (3-Months, 6-Months, 9-Months, 12-Months)
3 Year Pregnancy Rate
Pregnancy rate is defined as the cumulative percentage of pregnancies occuring within the time frame. The pregnancy rate was evaluated for all participants who underwent successful bilateral treatment and who had demonstrated tubal occlusion by hysterosalpingogram (HSG) at the end of the Waiting Period who have been followed for up to 3 years.
Time frame: 3 years